REKLAMA

SOPHARMA AD: Sales revenues for March 2021

2021-04-05 13:03
publikacja
2021-04-05 13:03
Spis treści:

1. REPORT

2. INFORMATION ABOUT THE ENTITY

3. SIGNATURE OF PERSONS REPRESENTING THE COMPANY


Spis załączników:
Sales_Revenues_for_March_2021_espi.pdf  (REPORT)

POLISH FINANCIAL SUPERVISION AUTHORITY
UNI - EN REPORT No 13 / 2021
Date of issue: 2021-04-05
Short name of the issuer
SOPHARMA AD
Subject
Sales revenues for March 2021
Official market - legal basis
art. 56. 1. 2 of Act on Public Offering.
Unofficial market - legal basis
Contents of the report:
Sofia, Bulgaria, April 5, 2021 – According to the requirements of art. 100t of LPOS, “Sopharma” AD (SFA: “BSE-Sofia” AD, SPH: Warsaw Stock Exchange) notifies that for March 2021 the Company recorded a decrease in sales of 56% compared to the same month of 2020, incl. 55% decrease in domestic sales and 12% decrease in export sales.
Annexes
File Description
Sales_Revenues_for_March_2021_espi.pdfSales_Revenues_for_March_2021_espi.pdf Sales revenues for March 2021

SOPHARMA AD
(fullname of the issuer)
SOPHARMA AD Farmaceutyczny (far)
(short name of the issuer) (sector according to clasification
of the WSE in Warsow)
1220 Sofia
(post code) (city)
IlienskoShosse 16
(street) (number)
+359 2 813 42 00 +359 2 936 02 86
(phone number) (fax)
(e-mail) (web site)
nd
(NIP) (REGON)

SIGNATURE OF PERSONS REPRESENTING THE COMPANY
Date Name Position / Function Signature
2021-04-05 Ognian Donev Executive Director
Źródło:GPW - komunikaty spółek (ESPI)
Tematy
Konto Firmowe i Karta przez rok za bezwarunkowe 0 zł

Konto Firmowe i Karta przez rok za bezwarunkowe 0 zł

Advertisement

Komentarze (0)

dodaj komentarz

Powiązane

Polecane

Najnowsze

Popularne

Ważne linki